Filing Details
GeoVax Labs, Inc. (NASDAQ:GOVX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 27, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:GOVX
GeoVax Labs, Inc. (GOVX) Files Quarterly Report for Q0
Filing Details GeoVax Labs, Inc. (NASDAQ:GOVX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 27, 2026. The Healthcare company reported…
Market Context
GeoVax Labs, Inc.'s stock currently trades at $0.76 with a market capitalization of $9.6M.
The 10-Q provides GeoVax Labs, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for GeoVax Labs, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GOVX Stock Page
Frequently Asked Questions
Where can I read GOVX's SEC filings?
Browse all filings on our GOVX SEC filings page.
What types of SEC filings does GeoVax Labs, Inc. file?
Public companies like GeoVax Labs, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.